Latest News in the pharma Industry

Research & Development

Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

30 Jul 2015

Read more 
Shire Receives CHMP Positive Opinion in Europe for Intuniv

Shire Receives CHMP Positive Opinion in Europe for Intuniv

24 Jul 2015

Read more 
Amgen Submits Supplemental New Drug Application for Kyprolis (Carfilzomib) in Relapsed Multiple Myeloma

Amgen Submits Supplemental New Drug Application for Kyprolis (Carfilzomib) in Relapsed Multiple Myeloma

24 Jul 2015

Read more 
AstraZeneca Provides Update On Selumetinib In Uveal Melanoma

AstraZeneca Provides Update On Selumetinib In Uveal Melanoma

23 Jul 2015

Read more 
Wyatt Technology Publishes Whitepaper on Protein Quality Control in High-Throughput Screening Studies

Wyatt Technology Publishes Whitepaper on Protein Quality Control in High-Throughput Screening Studies

22 Jul 2015

Read more 
New Study Shows Florbetapir F 18 Injection Scans Led to Change in Diagnosis and Management of Patients Being Evaluated for Cognitive Decline

New Study Shows Florbetapir F 18 Injection Scans Led to Change in Diagnosis and Management of Patients Being Evaluated for Cognitive Decline

22 Jul 2015

Read more 
CheckMate -025, a Pivotal Phase III Opdivo (Nivolumab) Renal Cell Cancer Trial, Stopped Early

CheckMate -025, a Pivotal Phase III Opdivo (Nivolumab) Renal Cell Cancer Trial, Stopped Early

20 Jul 2015

Read more 
Oxford Vaccines Group Initiates Phase II Study of the Ebola Prime-Boost Vaccine Regimen Combining MVA-BN Filo and Janssen's AdVac Technology

Oxford Vaccines Group Initiates Phase II Study of the Ebola Prime-Boost Vaccine Regimen Combining MVA-BN Filo and Janssen's AdVac Technology

15 Jul 2015

Read more 
MUSC and BMS Announce Translational Research Collaboration Focused on Fibrotic Diseases

MUSC and BMS Announce Translational Research Collaboration Focused on Fibrotic Diseases

15 Jul 2015

Read more 
Cristal Therapeutics and PX Biosolutions to Develop Vaccines Based on CriVac Nanotech Platform

Cristal Therapeutics and PX Biosolutions to Develop Vaccines Based on CriVac Nanotech Platform

14 Jul 2015

Read more 
CiMaas and PharmaCell Enter a Collaborative Agreement

CiMaas and PharmaCell Enter a Collaborative Agreement

13 Jul 2015

Read more 
In a Pivotal Study, Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumours in People With a Specific Type of Bladder Cancer

In a Pivotal Study, Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumours in People With a Specific Type of Bladder Cancer

13 Jul 2015

Read more